NewsNovo
Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) cleared every item on its 2026 annual meeting ballot on September 9, 2026, with 94.53% of eligible shares represented.
The case for a clean governance read is solid: both proposals passed and the board is intact.
What complicates it is one directorial vote that drew considerably more opposition than the other two nominees on the same Class II slate.
Of 58,603,121 shares outstanding as of the July 17, 2026, record date, 55,399,491 were cast in person or by proxy at the Kirkland, Washington meeting.
Keep reading